Overview

LumiQuick Diagnostics Inc., based in Santa Clara, California, develops, manufactures, and markets high-quality point-of-care tests and immunoassay kits for the global in vitro diagnostic market. Their product portfolio includes rapid tests for infectious diseases, cardiac markers, cancer markers, drugs of abuse, fertility hormones, and other disease markers.

Therapeutic areas

Infectious DiseasesCardiac MarkersCancer Markers

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Lumiquick Diagnostics Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.